Related references
Note: Only part of the references are listed.Somatic Mutations in MLH1 and MSH2 Are a Frequent Cause of Mismatch-Repair Deficiency in Lynch Syndrome-Like Tumors
Arjen R. Mensenkamp et al.
GASTROENTEROLOGY (2014)
External quality assessment of BRAF molecular analysis in melanoma
Zandra C. Deans et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Sarcoma Diagnosis in the Age of Molecular Pathology
Elizabeth G. Demicco
ADVANCES IN ANATOMIC PATHOLOGY (2013)
European Consensus Conference for external quality assessment in molecular pathology
J. H. van Krieken et al.
ANNALS OF ONCOLOGY (2013)
Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group
Jean-Francois Emile et al.
BMC CANCER (2013)
Technical and implementation issues in using next-generation sequencing of cancers in clinical practice
D. Ulahannan et al.
BRITISH JOURNAL OF CANCER (2013)
The European Medicines Agency review of vemurafenib (Zelboraf®) for the treatment of adult patients with BRAF 600 mutation-positive unresectable or metastatic melanoma: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use
Silvy da Rocha Dias et al.
EUROPEAN JOURNAL OF CANCER (2013)
Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment
Zandra C. Deans et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Molecular Diagnostic Profiling of Lung Cancer Specimens with a Semiconductor-Based Massive Parallel Sequencing Approach Feasibility, Costs, and Performance Compared with Conventional Sequencing
Volker Endris et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
Neal I. Lindeman et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Interlaboratory comparison of IDH mutation detection
Martin J. van den Bent et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Molecular neuro-oncology in clinical practice: a new horizon
Michael Weller et al.
LANCET ONCOLOGY (2013)
Panitumumab-FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Jean-Yves Douillard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis
Clare M. McCourt et al.
PLOS ONE (2013)
Molecular diagnostics of a single multifocal non-small cell lung cancer case using targeted next generation sequencing
Willemina R. R. Geurts-Giele et al.
VIRCHOWS ARCHIV (2013)
Guideline on the requirements of external quality assessment programs in molecular pathology
J. Han van Krieken et al.
VIRCHOWS ARCHIV (2013)
The UK NEQAS for Molecular Genetics scheme for gastrointestinal stromal tumour: findings and recommendations following four rounds of circulation
Newton A. C. S. Wong et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations
A. W. Langerak et al.
LEUKEMIA (2012)
Assuring the quality of next-generation sequencing in clinical laboratory practice
Amy S. Gargis et al.
NATURE BIOTECHNOLOGY (2012)
Tumour molecular profiling for deciding therapy-the French initiative
Frederique Nowak et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations
Erik Thunnissen et al.
VIRCHOWS ARCHIV (2012)
Molecular Genetics External Quality Assessment Pilot Scheme for KRAS Analysis in Metastatic Colorectal Cancer
Zandra C. Deans et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2011)
Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase
Patricia J. T. A. Groenen et al.
HISTOPATHOLOGY (2011)
Multiplex Mutation Screening by Mass Spectrometry Evaluation of 820 Cases from a Personalized Cancer Medicine Registry
Carol Beadling et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
External Quality Assessment for KRAS Testing Is Needed: Setup of a European Program and Report of the First Joined Regional Quality Assessment Rounds
Ellen Bellon et al.
ONCOLOGIST (2011)
REFLECTIONS AND PROPOSALS TO ASSURE QUALITY IN MOLECULAR DIAGNOSTICS
M. Raymaekers et al.
ACTA CLINICA BELGICA (2011)
A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory
Margot G. F. van Lier et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Comparison of Sanger Sequencing, Pyrosequencing, and Melting Curve Analysis for the Detection of KRAS Mutations Diagnostic and Clinical Implications
Athanasios C. Tsiatis et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Biomarkers as disease definition: Mantle cell lymphoma as an example
Johan H. J. M. van Krieken et al.
PROTEOMICS CLINICAL APPLICATIONS (2010)
Molecular pathology of sarcomas: concepts and clinical implications
Judith V. M. G. Bovee et al.
VIRCHOWS ARCHIV (2010)
Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours
J. Lasota et al.
HISTOPATHOLOGY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program
J. H. J. M. van Krieken et al.
VIRCHOWS ARCHIV (2008)
CDKN2A (INK4A-ARF) mutation analysis to distinguish cutaneous melanoma metastasis from a second primary melanoma
Willeke A. M. Blokx et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Improved reliability of lymphoma diagnostics via PCR-based clonality testing:: -: Report of the BIOMED-2 concerted action BHM4-CT98-3936
J. H. J. M. van Krieken et al.
LEUKEMIA (2007)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
DNA sequences from multiple amplifications reveal artifacts induced by cytosine deamination in ancient DNA
M Hofreiter et al.
NUCLEIC ACIDS RESEARCH (2001)
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
H Joensuu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
